SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Director/PDMR Shareholding

8 Mar 2017 07:00

RNS Number : 8101Y
Collagen Solutions PLC
08 March 2017
 

 

Collagen Solutions plc

("Collagen Solutions", the "Company" or the "Group")

 

8 March 2017

Grant of Options

 

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that options over 500,000 ordinary shares of 1p each in the Company ("Ordinary Shares") were granted on 7 March 2017 to Bradley Selman, VP Global Sales & Marketing ("Options").

 

The Options have an exercise period of ten years from grant and have an exercise price per Option of 5.75p. The Options vest in full upon the closing middle market price per Ordinary Share exceeding 27p or EPS for the relevant financial year achieving 1p during the exercise period.

 

- Ends -

 

Enquiries:

 

Collagen Solutions Plc

Contact via Walbrook

Jamal Rushdy, Chief Executive Officer

Gill Black, Chief Financial Officer

Cenkos Securities plc (Nominated Adviser and Broker)

Stephen Keys

Steve Cox

Callum Davidson

Tel: 0207 397 8900

 

 

Walbrook PR

Tel: 020 7933 8780 or collagen@walbrookpr.com

Mike Wort

Mob: 07900 608 002

Anna Dunphy

Mob: 07876 741 001

 

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Bradley Selman

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR (VP - Global Sales & Marketing - Executive Team Member)

b)

 

Initial notification /Amendment

 

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Collagen Solutions Plc

 

b)

 

LEI

 

 

N/A

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

 

Identification code

 

 

Option to acquire 1p ordinary shares in Collagen Solutions Plc

 

N/A

 

b)

 

Nature of the transaction

 

 

Grant of Options

c)

 

Price(s) and volume(s)

 

 

Price (exercise): 5.75p

Volume(s): 500,000

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

N/A

 

N/A

 

e)

 

Date of the transaction

 

 

7 March 2017

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKFDNPBKKCNK
Date   Source Headline
29th Apr 20208:28 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20204:25 pmRNSForm 8.3 - Collagen Solutions plc
27th Apr 20204:22 pmRNSForm 8 (OPD) - Collagen Solutions plc
27th Apr 20202:58 pmRNSForm 8.3 - Collagen Solutions plc
27th Apr 202011:05 amRNSForm 8.3 - Collagen Solutions plc
24th Apr 20202:51 pmRNSForm 8.3 - Collagen Solutions Plc
24th Apr 20202:45 pmRNSForm 8.3
24th Apr 202012:21 pmRNSForm 8.3 - Collagen Solutions Plc
24th Apr 20209:40 amRNSForm 8.5 (EPT/NON-RI)
24th Apr 20207:00 amRNSDirector/PDMR Shareholding
23rd Apr 202012:10 pmGNWForm 8.3 - Collagen Solutions Plc
23rd Apr 20207:00 amRNSTrading update
22nd Apr 20201:30 pmRNSForm 8.3 - Collagen Solutions plc
22nd Apr 20209:27 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20209:31 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20208:21 amRNSForm 8.5 (EPT/NON-RI)
17th Apr 20202:33 pmRNSForm 8.3 - Collagen Solutions plc
17th Apr 202012:35 pmRNSForm 8.3 - Collagen Solutions plc
17th Apr 20208:35 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 20207:00 amRNSStrategic Review and Formal Sale Process
18th Mar 20207:00 amRNSTrading update
3rd Dec 20197:00 amRNSHalf-year Report
19th Nov 20197:00 amRNSInvestor results presentation
13th Nov 20197:00 amRNSDirectorate Change
22nd Oct 20197:00 amRNSTrading Update & Notice of Results
3rd Oct 20197:00 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSInvestor presentation
28th Aug 201911:29 amRNSResult of AGM
28th Aug 20197:00 amRNSAGM Statement
8th Aug 201910:53 amRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSPosting of Annual Report and Notice of AGM
11th Jul 20197:00 amRNSDirector/PDMR Shareholding
9th Jul 201912:18 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSFinal Results
9th Jul 20197:00 amRNSDirectorate Change
13th Jun 20192:22 pmRNSNotice of Results
10th Jun 20195:13 pmRNSHolding(s) in Company
10th Jun 20195:09 pmRNSHolding(s) in Company
7th Jun 20199:38 amRNSHolding(s) in Company
6th Jun 20192:27 pmRNSHolding(s) in Company
6th Jun 201912:35 pmRNSHolding(s) in Company
6th Jun 20199:52 amRNSDirector/PDMR Shareholding
6th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 201911:50 amRNSResult of General Meeting and Open Offer
23rd May 20197:00 amRNSInvestor presentation
20th May 20197:00 amRNSStrategic Investment, Placing and Open Offer
9th Apr 20198:08 amEQSCollagen Solutions's losses narrow on improved top line performance
9th Apr 20197:00 amRNSTrading Update
21st Mar 201911:36 amRNSHolding(s) in Company
21st Feb 20192:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.